| HOME >> MEDICINE >> TECHNOLOGY |
Dendreon Corporation (US) II-44
Eli Lilly and Company (US) II-44
Emergent BioSolutions, Inc. (US) II-45
Genentech, Inc. (US) II-45
Johnson & Johnson (US) II-46
Centocor Ortho Biotech, Inc. (US) II-46
MedImmune, Inc. (US) II-46
Merck Serono S.A. (Switzerland) II-47
Schering-Plough Corporation (US) II-47
UCB Group (Belgium) II-47
Unigene Laboratories, Inc. (US) II-48
Vaccinogen, Inc. (US) II-48
6. GLOBAL MARKET PERSPECTIVE II-49
Table 4: World Recent Past, Current & Future Analysis for
Protein Drugs by Geographic Region - US and Rest of World
Markets Independently Analyzed with Annual Revenue Figures in
US$ Million for Years 2006 through 2015 (includes
corresponding Graph/Chart) II-49
Table 5: World 10-Year Perspective for Protein Drugs by
Geographic Region - Percentage Breakdown of Dollar Sales for
US and Rest of World Markets for Years 2006, 2009, and 2015 II-49
Table 6: World Recent Past, Current and Future Analysis for
Protein Drugs by Drug Type - Antibodies, Blood Products,
Cytokines, Peptide Hormones, Vaccines, and Other Drugs
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2015 (includes corresponding
Graph/Chart) II-50
Table 7: World 10-Year Perspective for Protein Drugs by Drug
Type - Percentage Breakdown of Dollar Sales for Antibodies,
Blood Products, Cytokines, Peptide Hormones, Vaccines, and
Other Drugs for Years 2006, 2009, and 2015 (includes
corresponding Graph/Chart) II-51
III. COMPETITIVE LANDSCAPE
Total Companies Profiled: 56 (including Divisions/Subsidiaries - 58)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 34
Canada 2
Japan 1
'/>"/>| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |